Continuing Support for the Inherited Alzheimer's Network
Bridge Funding for Dominantly Inherited Alzheimer Network
This funding helps keep an important network running that collects information from families with an inherited form of Alzheimer's disease.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-11298780 on NIH RePORTER |
What this research studies
This funding helps maintain the Dominantly Inherited Alzheimer Network (DIAN), which is crucial for understanding and preventing an inherited form of Alzheimer's disease. The network supports 16 sites and over 300 participants, collecting vital information over time. Without this support, the collection of important data and biological samples could stop, which would be a significant loss for future research. This bridge funding ensures that the network can continue its essential work, managing the study, collecting data, and sharing findings with the scientific community.
Who could benefit from this research
Good fit: This network primarily involves individuals and families affected by dominantly inherited forms of Alzheimer's disease.
Not a fit: Patients not currently part of the Dominantly Inherited Alzheimer Network would not directly benefit from this specific bridge funding.
Why it matters
Potential benefit: This continued support ensures that valuable long-term data and resources remain available to researchers, which is essential for developing future treatments and prevention strategies for inherited Alzheimer's disease.
How similar studies have performed: The Dominantly Inherited Alzheimer Network is a well-established and ongoing effort that has already contributed significantly to understanding inherited Alzheimer's disease.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Bateman, Randall J — Washington University
- Study coordinator: Bateman, Randall J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.